Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 119Neoplasms 100Lung Neoplasms 66Colorectal Neoplasms 60Carcinoma, Hepatocellular 56Carcinoma, Non-Small-Cell Lung 51Prostatic Neoplasms 47Pancreatic Neoplasms 37Uterine Cervical Neoplasms 35Stomach Neoplasms 29Ovarian Neoplasms 28Disease 28Rectal Neoplasms 27Multiple Myeloma 24Leukemia, Myeloid, Acute 21Head and Neck Neoplasms 21Endometrial Neoplasms 21Recurrence 20Esophageal Neoplasms 19Colonic Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Neoplasm Metastasis 17Glioblastoma 17Melanoma 15Lymphoma 15Glioma 15Cholangiocarcinoma 14Urinary Bladder Neoplasms 12Neoplasm, Residual 12Liver Neoplasms 12

Interventions

Verapamil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Multi Drug Resistant Organisms × Clear all
NCT07505446 2026-04-08

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Assiut University

Not yet recruiting
100 enrolled

Multi Drug Resistant Organisms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡